Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-270
Published Online: 2014-04-17
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Potthoff, Karin
Habl, Gregor
Bruckner, Thomas
Suppan, Christian
Hassel, Jessica
Jäger, Dirk
Indorf, Martin
Debus, Juergen
License valid from 2014-04-17